Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04957901

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

Sponsor: Sun Yat-sen University

View on ClinicalTrials.gov

Summary

The next-generation sequencing (NGS) based on liquid biopsy has been an emerging technology to identify tumor-specific genetic aberrations in malignant tumors. The tumor tissue (FFPE) and plasma samples from the newly diagnosed pediatric lymphoma patients were collected and sequenced by 475 genes panel before, during and post treatment, to evaluate the significance of the ctDNA in efficacy prediction, predicting recurrence or mechanism of resistance to chemotherapy for pediatric lymphoma.

Key Details

Gender

All

Age Range

1 Year - 18 Years

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2021-12-01

Completion Date

2026-06-01

Last Updated

2025-06-11

Healthy Volunteers

No

Conditions

Interventions

DRUG

Pediatric lymphoma protocol

The tumor tissue (FFPE) and plasma samples (bone marrow or cerebrospinal fluid samples if necessary) from the newly diagnosed patients were collected and sequenced by 475 genes panel before, during and post treatment.

Locations (1)

Yizhuo Zhang

Guangzhou, China